Viread (Tenofovir Disoproxil Fumarate)

The Latest

An Overview of Viread (Tenofovir)

Brand Name: Viread Other Names: TDF, tenofovir DF Drug Class: Nucleoside Reverse Transcriptase Inhibitors

By AIDSinfo

With the Public Attuned to Drug Pricing, Advocates Request Affordable Rate for New HIV Drug

The Fair Pricing Coalition says that patients, insurers and public programs shouldn't have to pay higher costs for a next-generation HIV treatment could make combination therapy less toxic.

By Jennifer Johnson Avril

Viread

Brand name: Viread

Generic name: tenofovir disoproxil fumarate (tenofovir), or TDF

Class: Nucleotide reverse transcriptase inhibitor(nucleotide, NtRTI, or nuke)

Manufacturer: Gilead Sciences, Inc., www.Viread.com, (800) GILEAD-5 (445-3235)

AWP: $...

By Positively Aware

Tenofovir (Viread)

What Is Tenofovir? Who Should Take Tenofovir? What About Drug Resistance? How Is Tenofovir Taken? What Are the Side Effects? How Does Tenofovir React With Other Drugs?

What Is Tenofovir?

Tenofovir (Viread), also called bis-POC PMPA, is ...

By AIDS InfoNet

Viread (Tenofovir)

Viread is supplied in 300-mg tablets that are almond shaped, light blue film coated, and embossed with "GILEAD" and "4331" on one side and with "300" on the other side.

Background Coformulations Dose Food Restrictions Storage Patient Assis...

By The Center for AIDS Information & Advocacy

Gilead Sciences First-Quarter Profits Driven by Increase in Sales of Antiretroviral Viread

Foster City, Calif.-based Gilead Sciences on Thursday announced first-quarter 2004 net profits of $114.4 million, up from a net loss of $438.1 million during the same quarter last year, an increase largely driven by sales of its antiretroviral drug V...

By Henry J. Kaiser Family Foundation

Atazanavir (Reyataz): New Recommendations if Combined With Tenofovir (Viread) -- and Warning on Viagra, Cialis, and Levitra

On March 19, 2004 the FDA notified the public of new prescribing information and precautions for atazanavir (brand name Reyataz), if taken in combination with tenofovir (Viread) -- and warned of risks with Viagra or similar drugs.

If atazanavir is t...

By AIDS Treatment News

U.S. Approves Emtriva; Gilead Hopes Viread/Emtriva Combo Will Compete With Combivir

Gilead Sciences received approval from the US Food and Drug Administration Wednesday for a new once-a-day AIDS drug, Emtriva. Known generically as emtricitabine, Emtriva is a nucleoside reverse transcriptase inhibitor. Gilead now hopes to combine Emt...

By CDC National Prevention Information Network

Tenofovir DF on the Horizon

A new drug application for Tenofovir disoproxil fumarate (Tenofovir DF) has been filed with the Food and Drug Administration by Gilead Sciences. Tenofovir DF, also known as PMPA, could be approved within the next six months.

Tenofovir DF is an inves...

By Liliana Eagan for AIDS Project Los Angeles

Tenofovir: FDA Hearing October 3, Public Comment Deadlines September 26

On October 3 the FDA's Antiviral Drugs Advisory Committee will hold a public hearing on tenofovir (full chemical name tenofovir disoproxil fumarate, or tenofovir DF; new brand name Viread™, an antiretroviral developed by Gilead Sciences and currently...

By John S. James for AIDS Treatment News